Business Trends– category –
-
China’s AsymBio Secures $184M to Dramatically Expand Biologics CDMO Capacity, Bolstering ADC Production
PharmaSource China Overview AsymBio, a Chinese biologics CDMO, secured approximately $184 million (1.2397 billion Yuan) in financing to substantially expand its manufacturing capacity, R&D capabilities, GMP manufacturing lines, and h... -
Bioengineering Strategies Overcome Liver Tropism to Improve Cardiac Targeting of LNPs for Heart Disease Therapy
Arteriosclerosis, Thrombosis, and Vascular Biology - American Heart Association Journals USA Overview Despite promise in cardiovascular disease treatment, nanomedicines face challenges of insufficient cardiac targeting and poor retention... -
VERVE-101 Achieves 53-69% LDL-C Reduction in Lipid Disorder Trials, Accelerating LNP-Based Gene Editing Therapeutics
PMC (Part of MDPI) Switzerland Overview VERVE-101, an in vivo base editing therapy targeting PCSK9 via mRNA-LNP delivery, has progressed to clinical trials (NCT05398029) for lipid disorders, showing significant LDL-C reductions of 53% to... -
Nanotechnology Revolutionizes Cancer Treatment: EPR Effect Enables Tumor-Selective Drug Delivery and Reduced Toxicity
HCG Oncology India Overview Nanotechnology is revolutionizing cancer treatment by delivering therapeutic drug doses to tumors while minimizing collateral damage to healthy tissue. Nano-drugs, engineered within nanocarrier platforms like ... -
Low-Intensity Focused Ultrasound and Microbubbles Temporarily Open Blood-Brain Barrier, Unlocking Brain Drug Delivery
Drug Target Review UK Overview Researchers are investigating low-intensity focused ultrasound (LIFU) combined with intravenously administered microbubbles to temporarily and reversibly increase the permeability of the blood-brain barrier... -
Bispecific Antibody-Conjugated Lipid Nanoparticles Achieve Cell-Specific mRNA Delivery, Overcoming Liver Tropism
ACS Publications USA Overview Researchers have developed a bispecific antibody-conjugated lipid nanoparticle (TbsAb-LNP) platform designed for precise, cell-specific mRNA delivery, effectively circumventing the inherent liver tropism of ... -
GAC Group to Equip Aion EVs with 400Wh/kg+ All-Solid-State Batteries by H2 2026, CATL & Toyota Also Show Progress
Intelligent Living International Overview GAC Group reconfirmed plans to integrate all-solid-state batteries with over 400 Wh/kg cell energy density into its Aion brand production vehicles by the second half of 2026, accelerating its ent... -
LG Energy Solution to Establish Dry Electrode Pilot Line for All-Solid-State Batteries in H2 2026
CNEVPost South Korea Overview LG Energy Solution announced plans to establish a pilot line for all-solid-state batteries using a dry electrode process in the second half of 2026, accelerating product development and preparation for mass ... -
Samsung SDI to Commence Mass Production of All-Solid-State Batteries with Over 900 Wh/L Energy Density at Ulsan Plant by H2 2027
Gasgoo South Korea Overview Samsung SDI announced plans to initiate mass production of all-solid-state batteries at its Ulsan plant in South Korea by the second half of 2027, aiming to be the first domestic battery maker to market the te... -
Hamamatsu Photonics Unveils New Industrial and Scientific Sensor Products, Including CMOS Line Image Sensors
Hamamatsu Photonics Japan Overview Hamamatsu Photonics has announced several new sensor products, including the CMOS line image sensor S15611W, high-speed Si PIN photodiodes S15152 and S17348 for YAG laser detection, surface-mount short-...
